Cytotoxic, the name implies an agent or process that is toxic to cells. Cytotoxic Drugs are also known as anti-cancer drugs. These drugs work by interrupting cell growth at particular phases in the growth cycle. It works inhibiting the growth of cells that are growing rapidly, for example cancer cells. Its mechanism of action involves weakening of the cell membrane which leads to lysis of the cell i.e. it explodes. Also these drugs may interfere with cell division so the cell stops growing and dividing. Thus cytotoxic drugs are primarily used to treat cancer as part of a chemotherapy regime. Whereas it has also been used for treating certain skin conditions such as psoriasis and rheumatoid arthritis. Cytotoxic drugs have severe side effects as it kill cancer cells but also damages normal and healthy cells.

Cytotoxic drugs market comprises of drugs with different molecules having different mechanism of action and are used during chemotherapy regimens. These drugs comes in oral as well as intravascular form. They are predominantly used in leukaemia and lymphomas and in conjunction with surgery, radiotherapy and immunotherapy to treat malignant tumours

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-2515

Cytotoxic Drugs Market: Drivers and Restraints

Cytotoxic drugs market is growing, this is attributed to the rising global prevalence of various cancers i.e. breast, prostate, skin, blood, gastrointestinal tract, and lungs etc. thus increasing demand of cytotoxic drugs for treating cancer is the primary factor boosting the revenue growth of cytotoxic drugs market over the forecast period. In addition to this, increase in the number of product launches and development of advanced therapeutic modalities are also driving the revenue growth of cytotoxic drugs market. Whereas factors such as growing prevalence of bone tumours, soft tissue sarcomas and rheumatoid arthritis also contribute to the revenue growth of cytotoxic drugs market. Also, availability of advanced cytotoxic drugs along with rising healthcare expenditure and growing insurance coverage drives the cytotoxic drugs market, thus providing enormous opportunities to the drug manufacturers within this market. However severe side-effects related to these drugs and pricing of cytotoxic drugs hampers the revenue growth of the market.

The Cytotoxic drugs market is segment based on the route of administration, drug type and end user

Cytotoxic drugs market is segmented into following types:

By Drug Type

• Alkylating Agents
• Antimetabolites
• Vinca Alkaloids
• Taxanes
• Epipodophyllo Toxin
• Camptothecin Analogues
• Miscellaneous

By Route of administration

• Oral
• Intravenous

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies  
• Online Pharmacies

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-2515

Cytotoxic DrugsMarket: Overview

Cytotoxic Drugs market is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well over the forecast period due to increasing prevalence of different types of cancer such as lung cancer, colorectal cancer, breast cancer, prostate cancer, blood cancer etc. Also the cytotoxic drugs market is expanding globally due to increasing number of new drug launches. The cytotoxic drugs are expected to grow with a fastest CAGR over the forecast period. Increasing competition among major companies in the market to develop newer drugs tend to drive the cytotoxic drugs market towards the growth curve.

Depending on geographic region, the cytotoxic drugs market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America is the largest regional market owing to high patient awareness levels regarding different types of malignant and benign tumors and its treatment options, in addition to this increasing healthcare expenditure and relatively larger number of R&D exercises pertaining to drug manufacturing and marketing etc. these factors contribute for significant revenue generation from the region.

Asia Pacific is expected to grow at the fastest CAGR because of increasing prevalence of cancer in the region thus boosting the market growth of cytotoxic drugs market throughout the forecast period.

Some of the players in cytotoxic drugs market includesEli Lilly and Company, Roche Diagnostics, Pfizer, Sanofi, Amgen Inc., Celgene Corporation, Novartis AG, GlaxoSmithKline PLC, Merck & Company, and Johnson and Johnson. Whereas some regionalplayers also have a significant presence in cytotoxic drugs market.

Browse Full Report@ http://www.futuremarketinsights.com/reports/cytotoxic-drugs-market